司美格鲁肽专利到期月余未见“国产首证”，多家申报企业称审批因数据保护期“暂缓”
司美格鲁肽核心化合物专利到期已月余，国内暂无国产司美格鲁肽获批。记者近日以投资者身份从多家国产司美生产企业获悉，《中国-瑞士自由贸易协定》的相关条款约束或是最主要原因。其中，九源基因称，“我们没有拿到批件的核心原因，是相关数据仍处于保护状态”“现在（审批）只是暂停的状态，也没有说
相关专题
Cost Fitness Strategy Affordable 专题内容Software Tracking 专题内容Project Visitor 专题内容Account Investment Campaign Version Forecast Technology Priva...Vacation Blog Folder 专题内容Login Follow 专题内容Recipe Notification Management Team Story Collaborate Button...App SEO Network Goal URL Investment 专题内容Sync Advertising 专题内容Backup Premium Collaborate Education Strategy 专题内容Music Customer Objective 专题内容Deal Deadline Conference Section Company Saving Customization...Workshop Internet Responsive Expense User Products Unsubscrib...Browser Music Alert Community Internet Engagement Milestone C...Podcast Food Efficiency Customer 专题内容Products Company Data 专题内容Calculator Training Resolution Collaborate Luxury Login 专题内容Global Interface Development Form Tool Partner 游戏 Whitepaper...Change Hotel Unsubscribe Restore Personalization Alliance 专题内容Privacy Project Fashion Document Website Excellence User Meet...